Altimmune, Inc. Stock News

Molina Healthcare (MOH) expects the buyout to complement its existing Medicaid business in Wisconsin.

Encompass Health (EHC) and BJC HealthCare's new rehabilitation hospital is expected to come online in 2024.

Teladoc (TDOC) will provide in-home and on-demand phlebotomy services for its Primary360 members with Scarlet Health's support.

Elevance Health (ELV) continues witnessing a rise in the usage of its virtual care services, which is a vital driver.

Pediatrix Medical (MD) is expected to boost its services across maternal-fetal medicine, neonatology and obstetrics, plus 18 pediatric subspecialty offerings.

Strategic alliances are bolstering Select Medical's (SEM) growth potential while mitigating the risk factor.

Universal Health's (UHS) acute care hospitals experience lower-than-expected patient volumes in the second quarter, inducing a decline in revenues and profits.

Here is how Altimmune, Inc. (ALT) and Chinook Therapeutics (KDNY) have performed compared to their sector so far this year.

Here is how Altimmune, Inc. (ALT) and Chinook Therapeutics (KDNY) have performed compared to their sector so far this year.

Results from phase 1b NAFLD study using pemvidutide are to be released 2nd half of 2022;Q3 of 2022 will be 12-week data and Q4 of 2022 will be 24-week data. It is estimated that the global NASH market

The JV between Select Medical (SEM) and Inova Health System is expected to own and operate a new 32-bed critical illness recovery facility.

Humana's (HUM) strategic acquisitions help it boost its footprint and expand the product portfolio.

Mednax's (MD) name change is expected to take effect following the closing bell on Jul 1, 2022.

HCA Healthcare's (HCA) aborted acquisition follows another abandoned buyout plan involving RWJBarnabas Health and Saint Peter's Healthcare System.

Currently, Centene (CNC) has $3.6 billion remaining under its share buyback program.